12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights significant pre-market movements in health care stocks on Monday. GT Biopharma, China Pharma Holdings, Kintara Therapeutics, PTC Therapeutics, China SXT Pharmaceuticals, and Cue Health saw notable gains, while Virios Therapeutics, Jaguar Health, Aesthetic Medical Intl, Akanda, Syra Health, and Tenon Medical experienced declines.
May 20, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aesthetic Medical Intl's stock fell 27.68% to $0.36 in pre-market trading.
The decline in Aesthetic Medical Intl's stock price indicates negative market sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Akanda's stock declined by 23.01% to $0.13 in pre-market trading.
The decline in Akanda's stock price suggests negative market sentiment.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Jaguar Health's stock fell 39.46% to $0.16 in pre-market trading after its Q1 earnings report was released four days ago.
The decline in Jaguar Health's stock price is attributed to the market's negative response to its Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Syra Health's stock decreased by 11.95% to $1.4 in pre-market trading.
The decrease in Syra Health's stock price indicates negative market sentiment.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Tenon Medical's stock decreased by 9.58% to $0.77 in pre-market trading after its Q1 earnings report was released four days ago.
The decline in Tenon Medical's stock price is attributed to the market's negative response to its Q1 earnings report.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Virios Therapeutics' stock fell 44.1% to $0.2 in pre-market trading.
The significant drop in Virios Therapeutics' stock price indicates negative market sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holdings' stock rose 42.9% to $0.47 in pre-market trading after its Q1 earnings report was released three days ago.
The increase in China Pharma Holdings' stock price is attributed to the market's positive response to its Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
GT Biopharma's stock rose 153.2% to $7.9 in pre-market trading following the release of its Q1 earnings report three days ago.
The significant rise in GT Biopharma's stock price is directly linked to the positive market reaction to its Q1 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cue Health's stock rose 24.48% to $0.12 in pre-market trading.
The increase in Cue Health's stock price suggests positive market sentiment.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Kintara Therapeutics' stock rose 28.95% to $0.18 in pre-market trading after its Q3 earnings report was released four days ago.
The rise in Kintara Therapeutics' stock price is due to the positive market reaction to its Q3 earnings report.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
PTC Therapeutics' stock rose 26.9% to $42.0 in pre-market trading.
The increase in PTC Therapeutics' stock price suggests positive market sentiment.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
China SXT Pharmaceuticals' stock increased by 25.21% to $1.44 in pre-market trading.
The rise in China SXT Pharmaceuticals' stock price indicates positive market sentiment.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 100